A Report on Non-Ionizing Radiation

FDA RF LItt Review

Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer, U.S. FDA, released February 10, 2020.

“[T]here is insufficient evidence to support a causal association between RFR exposure and tumorigenesis. There is a lack of clear dose-response relationship, a lack of consistent findings or specificity and a lack of biological mechanistic plausibility.”